PMA device
Surpass Streamline Flow Diverter
Stryker Neurovascular · Intracranial Aneurysm Flow Diverter (OUT, Class III) · First FDA decision Jul 13, 2018, newest Aug 5, 2022Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
1
Naming "Surpass Streamline"
MAUDE reports
132
Brand "Surpass Streamline", since 2015
PubMed studies
30
Mentioning "Surpass Streamline"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Surpass Streamline Flow Diverter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Surpass Streamline Flow DiverterPMA supplement
P170024-S010 · Decided Aug 5, 2022 · 291 days after receipt · Normal 180 Day Track No User Fee
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
P170024 · Decided Jul 13, 2018 · 347 days after receipt
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Surpass Streamline", any status and sponsor, newest update first.
Stryker NeurovascularPublic (SYK)
NCT05544045 · 11 participants · Start Jun 3, 2022 · Primary completion Sep 30, 2023
Device: Surpass Streamline Flow Diverter System · For: Aneurysm, Intracranial
Sites: Beijing, China; Shenzhen, China; Zhuhai, China · 15 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Surpass Streamline", and for the whole product code for context.
This brand
132 reports: 30 malfunction, 98 injury, 4 death
Whole product code OUT
10,961 reports: 7,308 malfunction, 3,152 injury, 499 death
Newest reports for this brand
3008881809-2025-00589 · Received Oct 30, 2025 · Event dated Jan 27, 2023
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Stroke/CVA; Transient Ischemic Attack; Thromboembolism
- SURPASS STREAMLINE 4.0MM X 20MM - CEMalfunction
3008881809-2024-00358 · Received Aug 8, 2024 · Event dated May 17, 2024
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3008881809-2024-00348 · Received Aug 2, 2024 · Event dated Jun 19, 2024
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Deformation Due to Compressive Stress; Activation Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Surpass Streamline"[tiab]. The summary above synthesizes these.
- A Review of Current Flow Diverters.
Yamada K, Imamura H, Ozaki S, et al. · J Neuroendovasc Ther · 2024Review
- Introduction: History and Development of Flow Diverter Technology and Evolution.
Kühn AL, Gounis MJ, Puri AS · Neurosurgery · 2020Introductory Journal Article
- Surpass Streamline Flow Diverter for the Treatment of Craniocervical Unruptured Dissecting Aneurysms: A Multi-Institutional Retrospective Study.
Lu D, Lei H, Fang W, et al. · World Neurosurg · 2025Multicenter Study, Research Support, Non-U.S. Gov't
- Safety and efficacy of the surpass streamline for intracranial aneurysms (SESSIA): A multi-center US experience pooled analysis.
Vivanco-Suarez J, Mendez-Ruiz A, Farooqui M, et al. · Interv Neuroradiol · 2023Multicenter Study
- Preliminary Experience of the Surpass Streamline Flow Diverter for Large and Giant Unruptured Internal Carotid Artery Aneurysms.
Teranishi K, Mishima Y, Taniguchi T, et al. · Neurol Med Chir (Tokyo) · 2022
- [Unruptured Intracranial Aneurysms:Endovascular Techniques and Devices:New Devices for Unruptured Intracranial Aneurysms].
Oishi H · No Shinkei Geka · 2023English Abstract
- Use of Surpass Streamline Flow Diverter for the Endovascular Treatment of Craniocervical Aneurysms: A Single-Institution Experience.
Achey RL, Winkelman R, Sheikhi L, et al. · World Neurosurg · 2022
- Surpass Streamline Flow-Diverter Embolization Device for Treatment of Iatrogenic and Traumatic Internal Carotid Artery Injuries.
Ghorbani M, Shojaei H, Bavand K, et al. · AJNR Am J Neuroradiol · 2018
- Technical advantages of a novel flow diverter in complex flow diversion: patient series.
Lei C, Heskett C, Fry L, et al. · J Neurosurg Case Lessons · 2023
- Flow Diverter Reconstruction of Internal Carotid Artery (Loop) Dissections with or without Associated Pseudoaneurysms.
Kühn AL, Singh J, Massari F, et al. · World Neurosurg · 2022
- Flow Diverter Performance for the Treatment of Intracranial Aneurysms: An International Multicenter Comparative Study.
Vivanco-Suarez J, Flores JEB, Rodriguez-Calienes A, et al. · Stroke Vasc Interv Neurol · 2023
- Flow Diversion for Intracranial Aneurysms in Large-Diameter Vessels: A Subanalysis From the SESSIA Study.
Vivanco-Suarez J, Rodriguez-Calienes A, Farooqui M, et al. · Stroke Vasc Interv Neurol · 2023
Other devices of this type
Also filed under product code OUT.
- Pipeline Flex Embolization Device with Shield TechnologyMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2021
- Flow Re-Direction Endoluminal Device (FRED®) SystemMicroVention, Inc. · PMA 2025
- Pipeline Embolization Devices,pipeline Flex Embolization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2015
- Pipeline Vantage Embolization Device with Shield TechnologyMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2025
- Surpass Elite Flow Diverter SystemStryker Neurovascular · PMA 2024
- FRED X SystemMicroVention, Inc. · PMA 2022
- Surpass Evolve Flow Diverter SystemStryker Neurovascular · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.